555
Participants
Start Date
August 11, 2015
Primary Completion Date
January 31, 2017
Study Completion Date
April 24, 2017
IDP-118 Lotion
IDP-118 lotion will be applied as per the instructions provided by the investigational center staff.
Valeant Site 29, New York
Valeant Site 39, Rochester
Valeant Site 11, Philadelphia
Valeant Site 26, Norfolk
Valeant Site 23, Lynchburg
Valeant Site 30, Charleston
Valeant Site 41, Snellville
Valeant Site 13, Sanford
Valeant Site 1, Miami
Valeant Site 28, Coral Gables
Valeant Site 37, North Miami Beach
Valeant Site 3, Boynton Beach
Valeant Site 6, Mobile
Valeant Site 15, Nashville
Valeant Site 19, Louisville
Valeant Site 14, Louisville
Valeant Site 17, South Bend
Valeant Site 35, Clinton Township
Valeant Site 16, Warren
Valeant Site 34, Detroit
Valeant Site 18, Fridley
Valeant Site 12, Olathe
Valeant Site 31, Omaha
Valeant Site 9, Dallas
Valeant Site 40, Houston
Valeant Site 8, Houston
Valeant Site 46, Katy
Valeant Site 22, Webster
Valeant Site 21, San Antonio
Valeant Site 7, San Antonio
Valeant Site 20, Pflugerville
Valeant Site 10, Englewood
Valeant Site 38, Salt Lake City
Valeant Site 33, Los Angeles
Valeant Site 43, Los Angeles
Valeant Site 24, Beverly Hills
Valeant Site 44, Santa Monica
Valeant Site 27, Encino
Valeant Site 32, Encinitas
Valeant Site 25, San Diego
Valeant Site 4, San Diego
Valeant Site 45, Sacramento
Valeant Site 36, Santa Rosa
Valeant Site 5, Portland
Valeant Site 42, Spokane
Valeant Site 2, East Windsor
Collaborators (1)
Dow Pharmaceutical Sciences
INDUSTRY
Bausch Health Americas, Inc.
INDUSTRY